NCT06646198View on ClinicalTrials.gov

TIPS Plus Half-dose Donafenib in AHCC with PVTT-associated Portal Hypertension

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 8, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

December 31, 2026

Conditions
Hepatocellular Carcinoma with PVTT
Interventions
PROCEDURE

Transjugular intrahepatic portosystemic shunt (TIPS)

Perform transjugular intrahepatic portosystemic shunt under the guidance of DSA

DRUG

Donafenib

Half-dose donafenib, 100mg BID P.O. unless any evidence of disease progression or unacceptable side effects.

Trial Locations (1)

510060

RECRUITING

Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Fei Gao

OTHER